ECSP972079A - NEW RETINOIDS - Google Patents

NEW RETINOIDS

Info

Publication number
ECSP972079A
ECSP972079A ECSP972079A ECSP972079A EC SP972079 A ECSP972079 A EC SP972079A EC SP972079 A ECSP972079 A EC SP972079A EC SP972079 A ECSP972079 A EC SP972079A
Authority
EC
Ecuador
Prior art keywords
alkyl
hydrogen
well
retinoids
epithelial lesions
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Peter Mohr
Michael Klaus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972079 priority Critical patent/ECSP972079A/en
Publication of ECSP972079A publication Critical patent/ECSP972079A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Retinoides de fórmula general (gráfico), en donde X1 es oxo o un grupo OR1 en la posición 4 ó 5; R1 es hidrógeno, alquilo o acilo; y R2 es hidrógeno o alquilo; los enlaces punteados son opcionalmente y un enlace doble 3,4 puede solamente estar presente cuando X está en la posición 5; así como las sales farmacéuticamente aceptables de los ácidos carboxílicos de fórmula Y, pueden emplearse para la terapia y profilaxis de transtornos dermatológicos que van acompañados de lesiones epiteliales, p ej. el acné y la psoriasis, así como lesiones epiteliales malignas, tumores y cambios precancerosos de la membrana de las mucosas de la boca, lengua, laringe, esófago, vejiga, cervix y colón.Retinoids of general formula (graph), wherein X1 is oxo or an OR1 group at position 4 or 5; R1 is hydrogen, alkyl or acyl; and R2 is hydrogen or alkyl; dotted bonds are optionally and a 3,4 double bond can only be present when X is in position 5; as well as the pharmaceutically acceptable salts of the carboxylic acids of formula Y, can be used for the therapy and prophylaxis of dermatological disorders that are accompanied by epithelial lesions, eg. acne and psoriasis, as well as malignant epithelial lesions, tumors, and precancerous changes of the mucous membrane of the mouth, tongue, larynx, esophagus, bladder, cervix, and colon.

ECSP972079 1997-04-14 1997-04-14 NEW RETINOIDS ECSP972079A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972079 ECSP972079A (en) 1997-04-14 1997-04-14 NEW RETINOIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972079 ECSP972079A (en) 1997-04-14 1997-04-14 NEW RETINOIDS

Publications (1)

Publication Number Publication Date
ECSP972079A true ECSP972079A (en) 1998-04-07

Family

ID=42042911

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972079 ECSP972079A (en) 1997-04-14 1997-04-14 NEW RETINOIDS

Country Status (1)

Country Link
EC (1) ECSP972079A (en)

Similar Documents

Publication Publication Date Title
BR0110499A (en) Selective gamma retinoids
IL132819A0 (en) Use of fumaric acid derivatives
PH31621A (en) Pharmaceutical compositions.
AR033599A1 (en) PROCEDURE FOR THE PREPARATION OF TIOTROPIO BROMIDE AND USE OF TROPENOL AND TROPENOLIC ESTER AS STARTING MATERIALS FOR THE PREPARATION OF TIOTROPIO BROMIDE
US20030073745A1 (en) Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
AR060568A1 (en) SUBSTITUTED BIFENYL CARBOXYL ACIDS AND THEIR DERIVATIVES
KR960017617A (en) Salicylic Acid Derivatives Used as Stabilizers in Oil-in-water Emulsions
UY30300A1 (en) TRIARY COMPOUNDS AND THEIR DERIVATIVES
EA001216B1 (en) Bicyclic aromatic compounds, pharmaceutical and cosmetic composition based thereof, and use of the cosmetic composition
DE69410081D1 (en) Intermediates for the production of endothelin receptor antagonist triterpene derivatives
ECSP972079A (en) NEW RETINOIDS
ES2171886T3 (en) MORPHINE AND DIAMORFINE SALTS OF ANIONIC ANALGESICS, NON-NARCOTICS, TYPE SUBSTITUTED CARBOXYL ACIDS.
KR930016100A (en) Pharmaceutical composition
ES2160214T3 (en) PIGMENT PRODUCTION PROCEDURE.
CA2202228A1 (en) Novel retinoids
ES2369892T3 (en) COMPOSITION AND METHOD TO PROMOTE HAIR GROWTH.
SE9103837D0 (en) FLUORESCENSE DIAGNOSIS OF CANCER USING DELTA-AMINOLEVULIC ACID
IT1269511B (en) AMINO-SULPHONIC ACID DERIVATIVES, THEIR USE IN THE SYNTHESIS OF PSEUDOPEPTIDES AND PROCEDURE FOR THEIR PREPARATION
ES2127748T3 (en) CARBOXYL ACID SALT ESTERIFICATION PROCEDURE.
HRP20110134T1 (en) Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
IT1244773B (en) N- (4,5-DIIDROSSI-E 4,5,8-TRIIDROSSI-9,10-DIIDRO-9,10-DIOSSO-2- ANTRACEN-IL) CARBONYL) AMINO ACIDS USABLE IN THE THERAPY OF OSTEOARTICULAR AFFECTIONS
AU2021240298A1 (en) Novel biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
ES2135693T3 (en) PROCEDURE FOR THE OBTAINING OF GLYCINIC ACIDS OR ESTERS OF N-SUBSTITUTED GLYCINIC ACIDS AND USE OF THE PROCEDURE FOR THE SYNTHESIS OF INDIGO.
SE7702908L (en) WAY TO PRODUCE NEW LACTON DERIVATIVES OF CYCLOPENTANOL
ECSP014053A (en) NEW GAMMA SELECTIVE RETINOIDS